Michaela A Dinan, Kayla L Stratton, Wendy M Leisenring, Yutaka Yasui, Eric J Chow, Emily S Tonorezos, Chaya S Moskowitz, Jennifer M Yeh, David Noyd, Gregory T Armstrong, Kevin C Oeffinger
{"title":"儿童癌症幸存者护理的基于治疗暴露的风险分层:来自儿童癌症幸存者研究的报告。","authors":"Michaela A Dinan, Kayla L Stratton, Wendy M Leisenring, Yutaka Yasui, Eric J Chow, Emily S Tonorezos, Chaya S Moskowitz, Jennifer M Yeh, David Noyd, Gregory T Armstrong, Kevin C Oeffinger","doi":"10.1093/jnci/djaf268","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>Treatment exposure-based risk-stratification of long-term cancer survivors may help inform health care in survivorship clinics. We used the large, diverse population of the Childhood Cancer Survivor Study (CCSS) to test a modified, exposure-based strata previously developed within United Kingdom to classify survivors with respect to risk of late morbidity and health-related mortality.</p><p><strong>Methods: </strong>Five-year survivors of childhood cancer were categorized into low, medium, and high-risk groups based on treatment exposures and diagnosis. Primary endpoints included cumulative health-related (ie, non-recurrence, non-external) late mortality and cumulative incidence of severe or fatal (CTCAE grade 3-5) chronic health conditions conditional on reaching age 20 without the outcome. Siblings were a comparison group for chronic health conditions. Cox proportional hazards models were adjusted for sex, race, ethnicity, and age at diagnosis.</p><p><strong>Results: </strong>Among 15,346 survivors diagnosed 1970-1999, the risk of developing a severe chronic condition by age 35 was 11.9% (95% CI 9.9-14.3%), 15.1% (13.7-16.6%) and 25.4% (24.3-26.5%) for low, medium, and high-risk survivors, respectively, and 6.9% (6.1-7.9%) for siblings. Multivariable analysis confirmed higher likelihood of developing a chronic condition in high (hazard ratio [HR] 2.9, 2.5- 3.4) and medium (HR 1.5, 1.3- 1.8) vs the low-risk group. Health-related mortality was similarly increased among high (HR 5.1, 3.8-7.0) and medium (HR 2.5, 1.8-3.4) risk groups, as well as Black vs Non-Hispanic White survivors (HR 1.7, 1.3-2.1).</p><p><strong>Conclusions: </strong>Exposure-based risk categorizations can provide generalized risk stratification regarding future chronic health conditions and early mortality and may be useful in guiding management of childhood cancer survivors.</p>","PeriodicalId":14809,"journal":{"name":"JNCI Journal of the National Cancer Institute","volume":" ","pages":""},"PeriodicalIF":7.2000,"publicationDate":"2025-09-14","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Treatment exposure-based risk-stratification for care of survivors of childhood cancer: a report from the childhood cancer survivor study.\",\"authors\":\"Michaela A Dinan, Kayla L Stratton, Wendy M Leisenring, Yutaka Yasui, Eric J Chow, Emily S Tonorezos, Chaya S Moskowitz, Jennifer M Yeh, David Noyd, Gregory T Armstrong, Kevin C Oeffinger\",\"doi\":\"10.1093/jnci/djaf268\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><strong>Background: </strong>Treatment exposure-based risk-stratification of long-term cancer survivors may help inform health care in survivorship clinics. We used the large, diverse population of the Childhood Cancer Survivor Study (CCSS) to test a modified, exposure-based strata previously developed within United Kingdom to classify survivors with respect to risk of late morbidity and health-related mortality.</p><p><strong>Methods: </strong>Five-year survivors of childhood cancer were categorized into low, medium, and high-risk groups based on treatment exposures and diagnosis. Primary endpoints included cumulative health-related (ie, non-recurrence, non-external) late mortality and cumulative incidence of severe or fatal (CTCAE grade 3-5) chronic health conditions conditional on reaching age 20 without the outcome. Siblings were a comparison group for chronic health conditions. Cox proportional hazards models were adjusted for sex, race, ethnicity, and age at diagnosis.</p><p><strong>Results: </strong>Among 15,346 survivors diagnosed 1970-1999, the risk of developing a severe chronic condition by age 35 was 11.9% (95% CI 9.9-14.3%), 15.1% (13.7-16.6%) and 25.4% (24.3-26.5%) for low, medium, and high-risk survivors, respectively, and 6.9% (6.1-7.9%) for siblings. Multivariable analysis confirmed higher likelihood of developing a chronic condition in high (hazard ratio [HR] 2.9, 2.5- 3.4) and medium (HR 1.5, 1.3- 1.8) vs the low-risk group. Health-related mortality was similarly increased among high (HR 5.1, 3.8-7.0) and medium (HR 2.5, 1.8-3.4) risk groups, as well as Black vs Non-Hispanic White survivors (HR 1.7, 1.3-2.1).</p><p><strong>Conclusions: </strong>Exposure-based risk categorizations can provide generalized risk stratification regarding future chronic health conditions and early mortality and may be useful in guiding management of childhood cancer survivors.</p>\",\"PeriodicalId\":14809,\"journal\":{\"name\":\"JNCI Journal of the National Cancer Institute\",\"volume\":\" \",\"pages\":\"\"},\"PeriodicalIF\":7.2000,\"publicationDate\":\"2025-09-14\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"JNCI Journal of the National Cancer Institute\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://doi.org/10.1093/jnci/djaf268\",\"RegionNum\":1,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q1\",\"JCRName\":\"ONCOLOGY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"JNCI Journal of the National Cancer Institute","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1093/jnci/djaf268","RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"ONCOLOGY","Score":null,"Total":0}
Treatment exposure-based risk-stratification for care of survivors of childhood cancer: a report from the childhood cancer survivor study.
Background: Treatment exposure-based risk-stratification of long-term cancer survivors may help inform health care in survivorship clinics. We used the large, diverse population of the Childhood Cancer Survivor Study (CCSS) to test a modified, exposure-based strata previously developed within United Kingdom to classify survivors with respect to risk of late morbidity and health-related mortality.
Methods: Five-year survivors of childhood cancer were categorized into low, medium, and high-risk groups based on treatment exposures and diagnosis. Primary endpoints included cumulative health-related (ie, non-recurrence, non-external) late mortality and cumulative incidence of severe or fatal (CTCAE grade 3-5) chronic health conditions conditional on reaching age 20 without the outcome. Siblings were a comparison group for chronic health conditions. Cox proportional hazards models were adjusted for sex, race, ethnicity, and age at diagnosis.
Results: Among 15,346 survivors diagnosed 1970-1999, the risk of developing a severe chronic condition by age 35 was 11.9% (95% CI 9.9-14.3%), 15.1% (13.7-16.6%) and 25.4% (24.3-26.5%) for low, medium, and high-risk survivors, respectively, and 6.9% (6.1-7.9%) for siblings. Multivariable analysis confirmed higher likelihood of developing a chronic condition in high (hazard ratio [HR] 2.9, 2.5- 3.4) and medium (HR 1.5, 1.3- 1.8) vs the low-risk group. Health-related mortality was similarly increased among high (HR 5.1, 3.8-7.0) and medium (HR 2.5, 1.8-3.4) risk groups, as well as Black vs Non-Hispanic White survivors (HR 1.7, 1.3-2.1).
Conclusions: Exposure-based risk categorizations can provide generalized risk stratification regarding future chronic health conditions and early mortality and may be useful in guiding management of childhood cancer survivors.
期刊介绍:
The Journal of the National Cancer Institute is a reputable publication that undergoes a peer-review process. It is available in both print (ISSN: 0027-8874) and online (ISSN: 1460-2105) formats, with 12 issues released annually. The journal's primary aim is to disseminate innovative and important discoveries in the field of cancer research, with specific emphasis on clinical, epidemiologic, behavioral, and health outcomes studies. Authors are encouraged to submit reviews, minireviews, and commentaries. The journal ensures that submitted manuscripts undergo a rigorous and expedited review to publish scientifically and medically significant findings in a timely manner.